Ren Xiaoping, Bachelor, Chief Physician, Professor.
Graduated from Harbin Medical University in 1984, and went to the Klanat Hand Microsurgery Center at the University of Louisville in the United States for training in 1996. Currently serves as the Director of the Department of Orthopedics and the Director of the Institute of Orthopedics at Ruikang Hospital affiliated with Guangxi University of Chinese Medicine, an academician in the Academy of the United Nations Sciences and Technology Organization, Russian Academy of Sciences and American Society for Surgery of the Hand.
Research direction: Spinal fusion surgery and Research on the combination of traditional Chinese and Western medicine for the prevention and treatment of orthopedic diseases.
Research situation: i. Designer of the world's first clinical model for allogeneic hand transplantation and participant of the first allogeneic hand transplantation in the United States; ii. Discoverer of International RPCT and RCI Phenomena; iii. The global leader in spinal cord fusion surgery for spinal cord injury paralysis.
Awards: i. In 2017, selected by the MIT Technology Review column as one of the top ten most attractive innovative technologies in the world today; ii. In 2021, received Vebleg Fellow from the United Nations Sciences and Technology Organization; iii. In 2022, won the third prize for scientific and technological progress from the Chinese Association of Integrative Medicine.
Ren Xiaoping, Bachelor, Chief Physician, Professor.
Graduated from Harbin Medical University in 1984, and went to the Klanat Hand Microsurgery Center at the University of Louisville in the United States for training in 1996. Currently serves as the Director of the Department of Orthopedics and the Director of the Institute of Orthopedics at Ruikang Hospital affiliated with Guangxi University of Chinese Medicine, an academician in the Academy of the United Nations Sciences and Technology Organization, Russian Academy of Sciences and American Society for Surgery of the Hand.
Research direction: Spinal fusion surgery and Research on the combination of traditional Chinese and Western medicine for the prevention and treatment of orthopedic diseases.
Research situation: i. Designer of the world's first clinical model for allogeneic hand transplantation and participant of the first allogeneic hand transplantation in the United States; ii. Discoverer of International RPCT and RCI Phenomena; iii. The global leader in spinal cord fusion surgery for spinal cord injury paralysis.
Awards: i. In 2017, selected by the MIT Technology Review column as one of the top ten most attractive innovative technologies in the world today; ii. In 2021, received Vebleg Fellow from the United Nations Sciences and Technology Organization; iii. In 2022, won the third prize for scientific and technological progress from the Chinese Association of Integrative Medicine.